Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Hospira Drops Sodium Thiopental

by Rick Mullin
January 31, 2011 | A version of this story appeared in Volume 89, Issue 5

Hospira, the only U.S.-based manufacturer of sodium thiopental, a sedative legally required in all lethal injections of U.S. death-row inmates, says it will halt production of the chemical. The company had been working on increasing production at its plant in Liscate, Italy, but the Italian parliament, invoking the European Union’s ban on capital punishment, required the company to ensure that the chemical would not be used in lethal injection. In a statement issued last week, the company, which works through wholesalers, said it could not prevent the drug from being diverted to departments of correction for use in executions. Hospira claims that it has never condoned the use of sodium thiopental for execution. The drug, the first one of three administered in U.S. lethal injections, is a rapid-onset short-acting barbiturate general anesthetic also used in various procedures in hospitals.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.